Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Potential of cannabinoids as treatments for autism spectrum disorders.
Nezgovorova V, Ferretti CJ, Taylor BP, Shanahan E, Uzunova G, Hong K, Devinsky O, Hollander E. Nezgovorova V, et al. J Psychiatr Res. 2021 May;137:194-201. doi: 10.1016/j.jpsychires.2021.02.048. Epub 2021 Feb 26. J Psychiatr Res. 2021. PMID: 33689997 Review.
Optimizing first line treatments for adults with OCD.
Nezgovorova V, Reid J, Fineberg NA, Hollander E. Nezgovorova V, et al. Compr Psychiatry. 2022 May;115:152305. doi: 10.1016/j.comppsych.2022.152305. Epub 2022 Mar 16. Compr Psychiatry. 2022. PMID: 35325671 Free article. Review.
Pharmacological Treatment of Body Dysmorphic Disorder.
Hong K, Nezgovorova V, Uzunova G, Schlussel D, Hollander E. Hong K, et al. Among authors: nezgovorova v. Curr Neuropharmacol. 2019;17(8):697-702. doi: 10.2174/1570159X16666180426153940. Curr Neuropharmacol. 2019. PMID: 29701157 Free PMC article. Review.
New perspectives in the treatment of body dysmorphic disorder.
Hong K, Nezgovorova V, Hollander E. Hong K, et al. Among authors: nezgovorova v. F1000Res. 2018 Mar 23;7:361. doi: 10.12688/f1000research.13700.1. eCollection 2018. F1000Res. 2018. PMID: 29636904 Free PMC article. Review.
Commentary on the article: "Maintenance of wellness in patients with obsessive-compulsive disorder who discontinue medication after exposure/response prevention augmentation A randomized clinical trial" Foa EB et al., JAMA Psychiatry. 2022;79(3):193-200 (1).
Fineberg NA, Hollander E, Grant JE, Chamberlain SR, Drummond LM, Pellegrini L, Laws KR, Wellsted D, Reid J, Nezgovorova V, Baldwin DS. Fineberg NA, et al. Among authors: nezgovorova v. Compr Psychiatry. 2022 Jul;116:152323. doi: 10.1016/j.comppsych.2022.152323. Epub 2022 Apr 28. Compr Psychiatry. 2022. PMID: 35537294 Free article. Clinical Trial. No abstract available.
Characterisation of asthma subgroups associated with circulating YKL-40 levels.
Gomez JL, Yan X, Holm CT, Grant N, Liu Q, Cohn L, Nezgovorova V, Meyers DA, Bleecker ER, Crisafi GM, Jarjour NN, Rogers L, Reibman J, Chupp GL; SARP Investigators. Gomez JL, et al. Among authors: nezgovorova v. Eur Respir J. 2017 Oct 12;50(4):1700800. doi: 10.1183/13993003.00800-2017. Print 2017 Oct. Eur Respir J. 2017. PMID: 29025889 Free PMC article.